{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:16:36Z","timestamp":1767968196591,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012655","name":"Qilu Hospital of Shandong University","doi-asserted-by":"publisher","award":["TS20190973"],"award-info":[{"award-number":["TS20190973"]}],"id":[{"id":"10.13039\/100012655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.mcp.2022.101860","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T23:50:03Z","timestamp":1663285803000},"page":"101860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The measurement of NRF2 and TP53 in blood expects radiotherapeutic sensitivity in patients with esophageal cancer"],"prefix":"10.1016","volume":"66","author":[{"given":"Huiqin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mcp.2022.101860_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"Suppl 8","key":"10.1016\/j.mcp.2022.101860_bib2","doi-asserted-by":"crossref","first-page":"S843","DOI":"10.21037\/jtd.2017.06.123","article-title":"Non responders to neoadjuvant chemoradiation for esophageal cancer: why better prediction is necessary","volume":"9","author":"den Bakker","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"Suppl 8","key":"10.1016\/j.mcp.2022.101860_bib3","doi-asserted-by":"crossref","first-page":"S773","DOI":"10.21037\/jtd.2017.04.29","article-title":"Predictive factors in the evaluation of treatment response to neoadjuvant chemoradiotherapy in patients with advanced esophageal squamous cell cancer","volume":"9","author":"Wong","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2159-8290.CD-16-0127","article-title":"Role of KEAP1\/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance","volume":"7","author":"Jeong","year":"2017","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.mcp.2022.101860_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ncb3380","article-title":"Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer","volume":"18","author":"Walerych","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib6","doi-asserted-by":"crossref","first-page":"e1217967","DOI":"10.1080\/23723556.2016.1217967","article-title":"Mutant p53-Nrf2 axis regulates the proteasome machinery in cancer","volume":"4","author":"Lisek","year":"2017","journal-title":"Mol. Cell. Oncol."},{"issue":"3","key":"10.1016\/j.mcp.2022.101860_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.gastro.2019.10.039","article-title":"Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer","volume":"158","author":"Azad","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.mcp.2022.101860_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","article-title":"Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7918","key":"10.1016\/j.mcp.2022.101860_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-022-04919-3","article-title":"Inflammatory memory and tissue adaptation in sickness and in health","volume":"607","author":"Naik","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mcp.2022.101860_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.mcp.2022.101860_bib12","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3390\/cancers12123856","article-title":"High expression of NRF2 is associated with increased tumor-infiltrating lymphocytes and cancer immunity in ER-positive\/HER2-negative breast cancer","volume":"12","author":"Oshi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mcp.2022.101860_bib13","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1038\/ncomms7702","article-title":"IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age","volume":"6","author":"Tsukamoto","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mcp.2022.101860_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccell.2022.04.004","article-title":"Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity","volume":"40","author":"Hailemichael","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib15","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1038\/s41467-021-26407-4","article-title":"Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy","volume":"12","author":"Bent","year":"2021","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.mcp.2022.101860_bib16","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1093\/nar\/gkab976","article-title":"RBM6 splicing factor promotes homologous recombination repair of double-strand breaks and modulates sensitivity to chemotherapeutic drugs","volume":"49","author":"Machour","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.mcp.2022.101860_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/ijms18071341","article-title":"RNA binding proteins and genome integrity","volume":"18","author":"Nishida","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mcp.2022.101860_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11912-021-01153-4","article-title":"Update on management of squamous cell esophageal cancer","volume":"24","author":"Waters","year":"2022","journal-title":"Curr. Oncol. Rep."},{"issue":"3","key":"10.1016\/j.mcp.2022.101860_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.5021","article-title":"Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species","volume":"244","author":"Kitano","year":"2018","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.mcp.2022.101860_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/s10434-017-6271-y","article-title":"Correlation between biomarker candidate proteins with the effect of neoadjuvant chemoradiation therapy on esophageal squamous cell carcinoma","volume":"25","author":"Noda","year":"2018","journal-title":"Ann. Surg Oncol."},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/s41467-017-01730-x","article-title":"Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations","volume":"8","author":"Deng","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.mcp.2022.101860_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/ijo.2015.3301","article-title":"Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells","volume":"48","author":"Zhao","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.mcp.2022.101860_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/ng.3421","article-title":"NRF2 regulates serine biosynthesis in non-small cell lung cancer","volume":"47","author":"DeNicola","year":"2015","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12964-018-0262-x","article-title":"Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction","volume":"16","author":"Feng","year":"2018","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12885-017-3907-z","article-title":"Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer","volume":"18","author":"Namani","year":"2018","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.mcp.2022.101860_bib26","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/jnci\/88.17.1222","article-title":"Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma","volume":"88","author":"Thorban","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.mcp.2022.101860_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/cells8070641","article-title":"Molecular and kinetic analyses of circulating tumor cells as predictive markers of treatment response in locally advanced rectal cancer patients","volume":"8","author":"Troncarelli Flores","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mcp.2022.101860_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/nyas.13681","article-title":"Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target","volume":"1434","author":"Ma","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.mcp.2022.101860_bib29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cell.2019.07.031","article-title":"The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase","volume":"178","author":"Sanghvi","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mcp.2022.101860_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/carcin\/bgx043","article-title":"Nrf2 promotes mutant K-ras\/p53-driven pancreatic carcinogenesis","volume":"38","author":"Hamada","year":"2017","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.mcp.2022.101860_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ccell.2017.10.011","article-title":"Stress-activated NRF2-MDM2 cascade controls neoplastic progression in pancreas","volume":"32","author":"Todoric","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.mcp.2022.101860_bib32","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.2016.327","article-title":"IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma","volume":"115","author":"Matsuoka","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcp.2022.101860_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"issue":"36","key":"10.1016\/j.mcp.2022.101860_bib34","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1038\/s41388-018-0314-0","article-title":"Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy","volume":"37","author":"Zhu","year":"2018","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.mcp.2022.101860_bib35","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1080\/15384101.2018.1496756","article-title":"Keaping\" a lid on lung cancer: the Keap1-Nrf2 pathway","volume":"17","author":"Best","year":"2018","journal-title":"Cell Cycle"}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850822000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:18:14Z","timestamp":1760192294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850822000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":35,"alternative-id":["S0890850822000718"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101860","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The measurement of NRF2 and TP53 in blood expects radiotherapeutic sensitivity in patients with esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2022.101860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101860"}}